Abstract:Distal renal tubular acidosis (RTA) with nerve deafness is caused by mutations in the ATP6V1B1 gene causing defective function of the H+ -ATPase proton pump. We report five acidotic children (four males) from four unrelated families: blood pH 7.21-7.33, serum bicarbonate 10.8-14.7 mEq/l, minimum urinary pH 6.5-7.1 and fractional excretion of bicarbonate in the presence of normal bicarbonatemia 1.1-5.7%. Growth retardation and nephrocalcinosis, but not hypercalciuria, were common presenting manifestations. Hear… Show more
“…In fact, normocalciuria is not uncommon at diagnosis in young dRTA patients (51 year). 4,14,15 As we all know, many factors can contribute to the differences in urinary calcium excretion, such as dietary, calcium absorption and hormonal control, as well as renal handling of calcium. Three (patient I-1, II-1 and IV-1) of the four patients with normocalciuria had evident signs of dehydration resulted by vomiting, fever, or other causes at diagnosis in this study.…”
Section: Discussionmentioning
confidence: 99%
“…The coding region and adjacent intronic segments of the ATP6V1B1 and SLC4A1 genes were amplified using of previously described primer pairs, respectively. 2,14 PCRs were performed in 50 lL of solution containing 0.2 mM dNTP, 0.03 U/lL Taq polymerase (Takara EX Taq Hot start version, DRR006B, Osaka, Japan), 2.0 mM MgCl 2 , 2.5 lL 10 Â PCR Mg 2+ -free buffer (Takara), approximately 50 ng genomic DNA and 1 mM of each primer. PCR was performed with an initial denaturation step at 95 C for 5 min, subsequently followed by 33 cycles with denaturation at 95 C for 45 s, annealing at 52-66 C for 45 s and elongation at 72 C for 45 s. PCR samples were subjected to bidirectional sequencing.…”
The objective of this study is to identify ATP6V1B1, ATP6V0A4 and SLC4A1 genes mutations and assess audiologic characteristics in six Chinese children with primary distal renal tubular acidosis from four unrelated families between the ages of 2 and 13 years. Both ATP6V0A4 and ATP6V1B1 genes were preferentially screened in all index cases by direct sequence analysis. If inconclusive then SLC4A1 gene should be analyzed for mutation. Their clinical features, hearing status and inner ear imaging structure were also investigated. Six loss-of-function mutations were identified in six patients. Two novel mutations were identified in either of ATP6V0A4 and ATP6V1B1 genes, respectively. Two probands from different kindreds with mutations in ATP6V1B1 presented early onset profound sensorineural hearing loss (SNHL) and enlarged vestibular aqueduct (EVA). Two from different families carrying ATP6V0A4 mutations manifested early onset moderate mixed HL and moderate SNHL, respectively, the former comorbid with EVA, while the latter not; however, both their elder sisters showed normal hearing and inner ear. These findings expand the spectrum of mutations in the ATP6V0A4 and ATP6V1B1 genes associated with primary dRTA. Our study confirms the association of EVA and mutations in either of these two genes. More studies are necessary to clarify the relationship between dRTA, SNHL, EVA, and gene mutations.
“…In fact, normocalciuria is not uncommon at diagnosis in young dRTA patients (51 year). 4,14,15 As we all know, many factors can contribute to the differences in urinary calcium excretion, such as dietary, calcium absorption and hormonal control, as well as renal handling of calcium. Three (patient I-1, II-1 and IV-1) of the four patients with normocalciuria had evident signs of dehydration resulted by vomiting, fever, or other causes at diagnosis in this study.…”
Section: Discussionmentioning
confidence: 99%
“…The coding region and adjacent intronic segments of the ATP6V1B1 and SLC4A1 genes were amplified using of previously described primer pairs, respectively. 2,14 PCRs were performed in 50 lL of solution containing 0.2 mM dNTP, 0.03 U/lL Taq polymerase (Takara EX Taq Hot start version, DRR006B, Osaka, Japan), 2.0 mM MgCl 2 , 2.5 lL 10 Â PCR Mg 2+ -free buffer (Takara), approximately 50 ng genomic DNA and 1 mM of each primer. PCR was performed with an initial denaturation step at 95 C for 5 min, subsequently followed by 33 cycles with denaturation at 95 C for 45 s, annealing at 52-66 C for 45 s and elongation at 72 C for 45 s. PCR samples were subjected to bidirectional sequencing.…”
The objective of this study is to identify ATP6V1B1, ATP6V0A4 and SLC4A1 genes mutations and assess audiologic characteristics in six Chinese children with primary distal renal tubular acidosis from four unrelated families between the ages of 2 and 13 years. Both ATP6V0A4 and ATP6V1B1 genes were preferentially screened in all index cases by direct sequence analysis. If inconclusive then SLC4A1 gene should be analyzed for mutation. Their clinical features, hearing status and inner ear imaging structure were also investigated. Six loss-of-function mutations were identified in six patients. Two novel mutations were identified in either of ATP6V0A4 and ATP6V1B1 genes, respectively. Two probands from different kindreds with mutations in ATP6V1B1 presented early onset profound sensorineural hearing loss (SNHL) and enlarged vestibular aqueduct (EVA). Two from different families carrying ATP6V0A4 mutations manifested early onset moderate mixed HL and moderate SNHL, respectively, the former comorbid with EVA, while the latter not; however, both their elder sisters showed normal hearing and inner ear. These findings expand the spectrum of mutations in the ATP6V0A4 and ATP6V1B1 genes associated with primary dRTA. Our study confirms the association of EVA and mutations in either of these two genes. More studies are necessary to clarify the relationship between dRTA, SNHL, EVA, and gene mutations.
“…Patient’s genetic data and previously published mutations [14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30] are presented in table 2. A mutation in CAII (c.583G>C, patient 4) that had never been reported before was found among them.…”
Section: Resultsmentioning
confidence: 99%
“…One possible mechanism may be related to their increased tendency to develop nephrocalcinosis complicated by renal stone disease [32]. We and others [21] clearly demonstrated that this group is prone to nephrocalcinosis compared to the CAII group. Nephrocalcinosis can impair tubular function by mechanical blockage of tubular fluid flow, followed by tubular atrophy, interstitial inflammation and interstitial fibrosis, and lead to the development of chronic kidney disease [33].…”
Background and Aims: Untreated renal tubular acidosis (RTA) can result in severe complications. We reviewed the clinical features of patients with mutations in two genes causing RTA and evaluated their developmental expression assuming that timing, symptom severity and complications may be related to its occurrence. Methods: Clinical data from 16 patients with RTA due to mutations in either ATP6V1B1 or CAII were retrospectively reviewed. Both genes’ localization and expression pattern in the developing human kidney were analyzed by real-time polymerase chain reaction and immunostaining. Results: RTA-presenting symptoms were non-specific. Patients with mutations in ATP6V1B1 had earlier presentation (4.9 vs. 11 months, p < 0.041) and longer time to diagnosis than patients with CAII mutations (5.8 vs. 57 months, p < 0.01). Patients with ATP6V1B1 mutations were more likely to develop chronic kidney disease than those with CAII mutations (follow-up GFR values: 89 vs. 110 ml/min/1.73 m2, respectively, p < 0.017), probably secondary to nephrocalcinosis. Both ATP6V1B1 and CAII were expressed early during human nephrogenesis, with relatively higher transcript levels of ATP6V1B1. Conclusions: There is considerable delay in establishing a diagnosis of both types of RTA, supporting the need for earlier biochemical investigation. RTA due to ATP6V1B1 mutations is associated with mild progressive loss of kidney function.
“…Table 1 summarizes the genetic and molecular basis, as well as the clinical, biochemical, and radiological findings useful to identify the subtype of RTA [1][2][3][4][5][6][7][8][9][10][11][12]. Information on acquired forms of RTA secondary to drugs and toxins or associated to systemic diseases is not included because this review mostly deals with congenital primary types of RTA, which are more frequently found in pediatric patients.…”
In the absence of a gastrointestinal origin, a maintained hyperchloremic metabolic acidosis must raise the diagnostic suspicion of renal tubular acidosis (RTA). Unlike adults, in whom RTA is usually secondary to acquired causes, children most often have primary forms of RTA resulting from an inherited genetic defect in the tubular proteins involved in the renal regulation of acid-base homeostasis. According to their pathophysiological basis, four types of RTA are distinguished. Distal type 1 RTA, proximal type 2 RTA, mixed-type 3 RTA, and type 4 RTA can be differentiated based on the family history, the presenting manifestations, the biochemical profile, and the radiological findings. Functional tests to explore the proximal wasting of bicarbonate and the urinary acidification capacity are also useful diagnostic tools. Although currently the molecular basis of the disease can frequently be discovered by gene analysis, patients with RTA must undergo a detailed clinical study and laboratory work-up in order to understand the pathophysiology of the disease and to warrant a correct and accurate diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.